Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03476343 · ClinicalTrials.gov registry record · NA
Clinical Use of a Neonatal MRI System
A NA study of Nicu MRI, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 386
- Enrollment target
- 1
- Study location
NCT03476343: Completed NA study of Nicu MRI, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03476343 is a NA study of Nicu MRI that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 386 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03476343, a NA study of Nicu MRI, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 386 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the present study is to continue clinical scanning on the NICU MRI with improved administrative processes and procedures, thereby making medically indicated, state of the art/high end MRI exams available to all infants treated at CCHMC.
Primary Outcome
Any observed physical changes will be recorded during and after scanning
Conditions Studied
Interventions
- DEVICE GE OPTIMA MR430s with HDx/GE Electronics
Study Locations (1)
Ohio
- NICU, Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 386 participants |
| Start Date | 2018-02-11 |
| Est. Completion | 2022-09-09 |
| Phase | NA |
What the finished NCT03476343 record still lists
NCT03476343 is an interventional study that assigns participants to a tested intervention. The registered 386 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Nicu MRI appearing as the primary indexed condition, and to 1 intervention - of which GE OPTIMA MR430s with HDx/GE Electronics is the first listed.
NCT03476343 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03476343 about?
NCT03476343 is a clinical study titled "Clinical Use of a Neonatal MRI System". The purpose of the present study is to continue clinical scanning on the NICU MRI with improved administrative processes and procedures, thereby making medically indicated, state of the art/high end MRI exams available to all infants treated at CCHMC.
What is the current status of trial NCT03476343?
This trial is currently completed. It is a NA study. The enrollment target is 386 participants. The study started on 2018-02-11. Estimated completion is 2022-09-09.
What conditions does trial NCT03476343 study?
This clinical trial studies the following conditions: Nicu MRI.
What interventions are being tested in trial NCT03476343?
The interventions under investigation include: GE OPTIMA MR430s with HDx/GE Electronics (DEVICE).
Who is sponsoring clinical trial NCT03476343?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03476343 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03476343's enrollment target sits among peer trials
386 271st of 2000 higher than 1,730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645107 · 386 participants · Phase 3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- NCT05896189 · 386 participants · NA
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
- NCT06686121 · 386 participants · Phase 3
Improving Mobility After Revascularization in Peripheral Artery Disease
- NCT07424547 · 386 participants · Phase 1
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI